Skip to content
POM-V Prescription Required Companion Animal

Eurican DAPPi Lyophilisate and Solvent for Suspension for Injection

Active ingredients: Canine adenovirus, Canine distemper virus, Canine parainfluenza virus, Canine parvovirus

Form

Injection

Species

Dogs

Manufacturer

Boehringer Ingelheim Vetmedica GmbH

VMD MA No.

61700/3038

What it's used for

Duration of immunity: at least one year after the second injection of the primary vaccination course. Current available challenge and serological data show...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Canine adenovirus + Canine d...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Eurican DAPPi Lyophilisate and Solvent for Suspension for Injection — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Duration of immunity: at least one year after the second injection of the primary
vaccination course.
Current available challenge and serological data show that protection for distemper
virus, adenovirus and parvovirus* lasts for 2 years after primary vaccination course
followed by a first annual booster.
Any decision to adapt the vaccination schedule of this veterinary medicinal product
needs to be made
on a case by case basis, taking into account the vaccination history of the dog and
the epidemiological
context.
*Protection has been demonstrated against canine parvovirus type 2a, 2b and 2c
either by challenge (type 2b) or serology (type 2a and 2c).
contents of the reconstituted vial should be administered as a single dose.
The reconstituted content shall be an opalescent yellow to orange suspension.
Inject a 1 ml dose subcutaneously according to the following schedule:
Primary vaccination: Two injections separated by an interval of 4 weeks from
7 weeks of age.
When administered with Boehringer Ingelheim's vaccines containing rabies, the
minimum age for vaccination is 12 weeks of age.
In cases where high levels of maternally derived antibodies are suspected by the
veterinarian and the primary vaccination course was completed before 16 weeks of
age, a third injection using a Boehringer Ingelheim vaccine containing Distemper,
Adenovirus and Parvovirus is recommended from 16 weeks of age, at least 3 weeks
after the second injection.
Revaccination: Administer one dose 12 months after completion of the primary
vaccination course. Dogs should be revaccinated with a single booster dose on an
annual basis.
None.
Dogs:
Common
(1 to 10 animals / 100 animals
treated):
Injection site swelling
, injection site
pruritus, injection site pain.
Lethargy
.
Emesis
.
Uncommon
(1 to 10 animals / 1,000 animals
treated):
Anorexia, polydipsia, hyperthermia.
Diarrhoea.
Muscle tremor.
Muscle weakness.
Injection site warmth, injection site lesions
.
Rare
(1 to 10 animals / 10,000 animals
treated):
Hypersensitivity reaction (facial oedema,
anaphylactic shock, urticaria)
.
Slight (≤ 2 cm), immediately after injection. It usually regresses within 1-6 days.
Transient.
Cutaneous.
Some of which are life-threatening. Appropriate symptomatic treatment should
promptly be provided.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
Vaccinate healthy animals only.

Special precautions for safe use in the target species:
Apply usual aseptic procedures.
After vaccination, the live CAV-2 and CPV vaccine strains can transiently be shed
without adverse consequence for in-contact animals.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.

Amended pages: January 2026
Safety and efficacy data are available which demonstrate that this vaccine can be
administered with Eurican LR, Eurican L, Eurican Lmulti or Eurican L4 vaccines
(used as solvent) where available.
Safety and efficacy data are available which demonstrate that this vaccine can be
administered on the same day but not mixed with Rabisin.
When administered with Boehringer Ingelheim's vaccines containing rabies, the
minimum age for vaccination is 12 weeks of age.
When mixed with the Eurican LR vaccine a small and transient nodule (maximum
size 1.5 cm) at the injection site may be induced due to the presence of aluminium
hydroxide and a slight swelling (~4 cm) may occur after the injection at injection site,
regressing generally within 1-4 days.
When mixed with the Eurican L4 vaccine a swelling (less than 6 cm) may very
commonly occur at the injection site, disappearing within 8 days, anorexia may
commonly occur and vocalisation, tachycardia and tachypnoea may uncommonly be

Amended pages: January 2026
observed. For Eurican L4, no safety data in pregnant bitches are available for the
additional inactivated strain, Leptospira Australis.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product except the products mentioned above. A
decision to use this vaccine before or after any other veterinary medicinal product
therefore needs to be made on a case by case basis.
Lyophilisate and solvent:
Store and transport refrigerated (2 C – 8 C).
Protect from light.
Do not freeze.
Not applicable.

Amended pages: January 2026

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.